Cue Biopharma Inc

NASDAQ:CUE   12:23:23 AM EDT
3.52
0.00 (0.00%)
Earnings Announcements

Cue Biopharma Reports Third Quarter 2022 Financial Results

Published: 11/14/2022 21:17 GMT
Cue Biopharma Inc (CUE) - Cue Biopharma Reports Third Quarter 2022 Financial Results.
Qtrly Net Loss per Common Share $0.31.
Q3 Earnings per Share View $-0.38 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.1 Million
Adjusted EPS is expected to be -$0.32

Next Quarter Revenue Guidance is expected to be $0.29 Million
Next Quarter EPS Guidance is expected to be -$0.31

More details on our Analysts Page.